Next Article in Journal
Unexplained Vascular Pulmonary Nodule
Previous Article in Journal
Asymptomatic Patient with “Lumpy and Bumpy” Airways. A Case of Pulmonary MALToma
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

SARS-CoV-2 Lung Disease in a Patient with Pulmonary Sarcoidosis—Case Report

by
Lucyna Magdalena Opoka
1,*,
Dorota Wyrostkiewicz
2,
Jolanta Winek
3,
Katarzyna Błasińska
4,
Joanna Miłkowska-Dymanowska
4 and
Monika Szturmowicz
2
1
Department of Radiology, National Tuberculosis and Lung Diseases R esearch Institute, Warsaw, Poland
2
1st Department of Lung Diseases, National T uberculosis and Lung Diseases R esearch Institute, Warsaw, Poland
3
Outpatients’ Clinic, National Tuberculosis and Lung Diseases Research Institute, Outpatients’ Clinic, National Tuberculosis and Lung Diseases R esearch Institute, Warsaw, Poland
4
Department of Pneumonology and Allergology, Medical University, Lodz, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2020, 88(6), 620-625; https://doi.org/10.5603/ARM.a2020.0199
Submission received: 20 November 2020 / Revised: 18 December 2020 / Accepted: 18 December 2020 / Published: 30 December 2020

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the recently identified cause of the current pandemic. In patients with chronic respiratory lung diseases, SARS-CoV-2 may result in significant morbidity and increased mortality. We present a case of a 69-year-old male with stage II pulmonary sarcoidosis who had been under observation for 30 months without immunosuppressive treatment. He then developed severe SARS-CoV-2 disease with typical radiological and laboratory findings. Therapy with oxygen, antibiotics, low-molecular-weight heparin in a prophylactic dose, and dexamethasone resulted in marked clinical improvement. We will discuss the rationale for corticosteroid use in both SARS-CoV-2 disease and in SARS-CoV-2 disease that is complicating comorbid sarcoidosis.
Keywords: SARS-CoV-2; sarcoidosis, corticosteroids; anticoagulation; computed tomography SARS-CoV-2; sarcoidosis, corticosteroids; anticoagulation; computed tomography

Share and Cite

MDPI and ACS Style

Opoka, L.M.; Wyrostkiewicz, D.; Winek, J.; Błasińska, K.; Miłkowska-Dymanowska, J.; Szturmowicz, M. SARS-CoV-2 Lung Disease in a Patient with Pulmonary Sarcoidosis—Case Report. Adv. Respir. Med. 2020, 88, 620-625. https://doi.org/10.5603/ARM.a2020.0199

AMA Style

Opoka LM, Wyrostkiewicz D, Winek J, Błasińska K, Miłkowska-Dymanowska J, Szturmowicz M. SARS-CoV-2 Lung Disease in a Patient with Pulmonary Sarcoidosis—Case Report. Advances in Respiratory Medicine. 2020; 88(6):620-625. https://doi.org/10.5603/ARM.a2020.0199

Chicago/Turabian Style

Opoka, Lucyna Magdalena, Dorota Wyrostkiewicz, Jolanta Winek, Katarzyna Błasińska, Joanna Miłkowska-Dymanowska, and Monika Szturmowicz. 2020. "SARS-CoV-2 Lung Disease in a Patient with Pulmonary Sarcoidosis—Case Report" Advances in Respiratory Medicine 88, no. 6: 620-625. https://doi.org/10.5603/ARM.a2020.0199

Article Metrics

Back to TopTop